These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3093596)

  • 21. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasodilator therapy for chronic left ventricular failure.
    Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
    Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
    Artese D; Albani A; Di Tomasso E
    Minerva Med; 1983 Mar; 74(13):715-22. PubMed ID: 6220231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.
    Johnson G; Carson P; Francis GS; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
    Ruksin VV
    Sov Med; 1985; (2):54-6. PubMed ID: 3992326
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
    Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of peripheral vasodilators with different mechanisms of action in treating heart failure patients].
    Novikov SV; Mareev VIu; Elizarova NA; Naumov VG; Sazonova LN
    Ter Arkh; 1987; 59(9):126-30. PubMed ID: 3424177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydralazine in heart failure.
    Chatterjee K
    Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Congestive cardiomyopathy: value of short and long-term vasodilator treatment and prognosis].
    Grec V; Grbic M; Sigwart U
    Schweiz Med Wochenschr; 1983 Apr; 113(14):497-504. PubMed ID: 6545059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term vasodilator therapy for heart failure: noninvasive evaluation and noninvasive predictors of survival.
    Riecansky I
    Acta Cardiol; 1995; 50(3):209-13. PubMed ID: 7676760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
    Verma SP; Silke B; Reynolds GW; Kelly JG; Richmond A; Taylor SH
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):274-81. PubMed ID: 1381019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic treatment of dilated cardiomyopathy with special reference to the role of beta-blockers.
    Waagstein F
    Herz; 1985 Jun; 10(3):143-8. PubMed ID: 2862098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does closely monitored control and therapy adjustment improve the prognosis in patients with severe heart insufficiency?].
    Bertel O; Conen D; Schwarz U; Besch W; Dubach UC
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1820-3. PubMed ID: 4089581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
    Massie B; Kramer B; Haughom F
    Circulation; 1981 Mar; 63(3):658-64. PubMed ID: 6780233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy.
    Unverferth DV; Mehegan JP; Magorien RD; Unverferth BJ; Leier CV
    Am J Cardiol; 1983 May; 51(8):1392-8. PubMed ID: 6682617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of isosorbide dinitrate in management of chronic congestive heart failure.
    Parmley WW
    Am Heart J; 1985 Jul; 110(1 Pt 2):264-8. PubMed ID: 3893081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.